Scientists unlock mysterious structure of eye protein linked to blindness

1 min read

The cryo-electron microscopy (cryo-EM) structure of the transient receptor potential melastatin 1 (TRPM1) protein has provided unprecedented insight into its molecular architecture, shedding light on its role as a crucial component of vision in dim light. The researchers isolated TRPM1 and subjected it to cryo-EM analysis, which allowed them to determine its three-dimensional structure with high resolution.

The resulting structure reveals a non-canonical architecture for TRPM1, with an inverted transmembrane domain that differs from other members of the TRPM family, which are known ion channels. The intracellular domain adopts a canonical tetrameric fold, consistent with those of other TRPM family members. However, the transmembrane domain features a voltage sensor-like domain (VSLD) and pore domain (PD), typically arranged in a specific handedness, but here they are inverted, forming a large pore-like structure.

This unexpected arrangement suggests that TRPM1 may function as an ion channel despite its sequence similarity to other non-functional TRPM proteins. The researchers propose that the unique transmembrane architecture of TRPM1 enables it to form a functional pore, allowing for the passage of ions and potentially influencing its role in vision. Furthermore, this non-canonical structure may confer distinct permeation and pharmacological properties.

The discovery highlights the complex nature of protein function and the importance of structural analysis in understanding their mechanisms. As researchers continue to unravel the mysteries of TRPM1, they may uncover new avenues for treating diseases related to vision and other ion channel-related disorders. This work serves as a poignant reminder that even seemingly well-understood proteins can harbor unexpected secrets, underscoring the awe-inspiring complexity of the biological world.

1 min read

In a small village nestled between mountains, there lived a young girl named Maria who could see the stars only when the sun had long since set. She relied on her family and community to navigate the world during the day, but at night, she was lost in darkness. This is how complete congenital stationary night blindness affects some children around the world.

Researchers have been trying to understand the root of this condition for years. One protein, called TRPM1, plays a crucial role in vision in dim light. However, its structure and function were shrouded in mystery due to its complex biochemical behaviors. Recently, scientists successfully isolated TRPM1 and used advanced imaging techniques to determine its three-dimensional structure.

The researchers found that the structure of TRPM1 is different from other similar proteins - it has a non-canonical architecture with an "inverted" transmembrane domain. This unique arrangement allows the protein to form a large pore-like structure, which may enable it to function as an ion channel and support Maria's ability to see in low light conditions.

1 min read

Two scientists made a remarkable discovery about a protein called TRPM1 that helps us see in low light. Normally, this protein forms a special shape with four parts that work together to let ions pass through its membrane.

But the researchers found something surprising - TRPM1 actually has a different shape than expected. Its "back" part is like it should be, but its front part, where the important voltage sensor and pore are supposed to be, is flipped around in a way that's not seen in other similar proteins. This unusual structure might help us understand how TRPM1 works better and why some people can't see well at night because of mutations in this protein.